| 摘要 |
DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, obesity, wherein, the variables shown in the structural formula (I) are as defined in the specification.
|
| 申请人 |
ASTRAZENECA AB |
发明人 |
BAUER, UDO, ANDREAS;BIRCH, ALAN, MARTIN;BUTLIN, ROGER, JOHN;GREEN, CLIVE;BARLIND, JONAS, GUNNAR;HOVLAND, RAGNAR;JOHANNESSON, PETRA;JOHANSSON, JAN, MAGNUS;LEACH, ANDREW;NOESKE, ALEXANDER, TOBIAS;PETERSSON, ANNIKA, ULRIKA |
